Product Information
RITALIN 20 MG TABLET is a brand product labeled by Sandoz Inc., priced at $1.6333 per EA under NDC 66758027501. Its NADAC has been published 88 times since Jan 29, 2025.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
20 mg/1
Manufacturer
Sandoz Inc.NDC
66758027501
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
METHYLPHENIDATE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA010187FDA Approved
Before 1982
TE Code
AB
On Market Since
12/31/1955
Pharmacological Classes
Price Statistics
The NADAC for RITALIN 20 MG TABLET has been published 88 times since Jan 29, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.6333 per EA |
|---|---|
| All-time high | $1.6404 (Jun 11, 2025) |
| All-time low | $1.6229 (Jun 18, 2025) |
| 52-week high | $1.6333 |
| 52-week low | $1.6262 |
| Median price | $1.6312 |
| Average price | $1.6318 |
| Largest weekly change | -1.1% (Jun 18, 2025) |
| Weeks tracked | 88 |
| Tracking since | Jan 29, 2025 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sandoz Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
methylphenidate hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Central Nervous System Stimulant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of RITALIN 20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for RITALIN 20 MG TABLET, manufactured by Sandoz Inc., is $1.6333 per EA (NDC 66758027501), effective Sep 30, 2026.
How has the price of RITALIN 20 MG TABLET changed over time?
Over the history we have for it, the NADAC for RITALIN 20 MG TABLET has held within roughly two percent of its current level. It has been tracked across 88 weekly CMS publications since Jan 29, 2025.
What are the highest and lowest recorded NADAC prices for RITALIN 20 MG TABLET?
Since Jan 29, 2025, the NADAC for RITALIN 20 MG TABLET has ranged from a low of $1.6229 (Jun 18, 2025) to a high of $1.6404 (Jun 11, 2025), with a median of $1.6312 per EA.
Are there cheaper alternatives to RITALIN 20 MG TABLET?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, RITALIN 20 MG TABLET, is $1.6330 per EA — about 0% below RITALIN 20 MG TABLET.
Who manufactures RITALIN 20 MG TABLET?
RITALIN 20 MG TABLET (NDC 66758027501) is labeled by Sandoz Inc., and CMS classifies it as a brand product.